Literature DB >> 30015230

Murine models of vascular endothelial injury: Techniques and pathophysiology.

Yue Wu1, Sheng-An Su1, Yao Xie1, Jian Shen1, Wei Zhu2, Meixiang Xiang3.   

Abstract

Vascular endothelial injury (VEI) triggers pathological processes in various cardiovascular diseases, such as coronary heart disease and hypertension. To further elucidate the in vivo pathological mechanisms of VEI, many animal models have been established. For the easiness of genetic manipulation and feeding, murine models become most commonly applied for investigating VEI. Subsequently, countless valuable information concerning pathogenesis has been obtained and therapeutic strategies for VEI have been developed. This review will highlight some typical murine VEI models from the perspectives of pharmacological intervention, surgery and genetic manipulation. The techniques, pathophysiology, advantages, disadvantages and the experimental purpose of each model will also be discussed.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genetic manipulation; Pharmacological intervention; Surgery; Vascular endothelial injury model

Mesh:

Year:  2018        PMID: 30015230     DOI: 10.1016/j.thromres.2018.07.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

Review 1.  Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways.

Authors:  Tianwei Meng; Xinghua Li; Chengjia Li; Jiawen Liu; Hong Chang; Nan Jiang; Jiarui Li; Yabin Zhou; Zhiping Liu
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

2.  Endothelial progenitor cells-derived exosomes transfer microRNA-30e-5p to regulate Erastin-induced ferroptosis in human umbilical vein endothelial cells via the specificity protein 1/adenosine monophosphate-activated protein kinase axis.

Authors:  Jia Xia; Xiaoying Song; Jing Meng; Danfei Lou
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.